[PDF] Top 20 Discriminación en el Perú : acercamiento bibliográfico

... the formulation and evaluation of matrix tablet of Metformin HCL using natural mucilage of Cassia tora as a release ...The matrix tablet was ... See full document

... the formulation and in-vitro characterization of sustained release matrix tablets of Ambroxol hydrochloride, a potent mucolytic agent used in the treatment of respiratory ... See full document

... complications. Metformin hydrochloride is an orally administered biguanide, widely used in the management of type-2 diabetes, a common disease that combines defects of both insulin secretion and insulin ... See full document

... vitro release studies of different formulations of metformin (MG1-MG5) were performed in pH ...drug release. To further sustain the release of drug over a longer period of time, these batches ... See full document

... rotating paddle type (Model Electrolab, India). All the batches of tablets were evaluated (3 runs for each batch) using 900 ml of sequential gastrointestinal release medium, i.e. 0.1N hydrochloric acid (pH 1.2) ... See full document

... the matrix tablets of Metformin ...and characterization of ...cumulative release was found to be satisfactory with 93.14% and formulation was found to be stable at 40 0 C±2 0 C and 75% ... See full document

... the release rates in hydrophilic matrix tablets prepared by wet granulation ...better sustained release pattern compared to Eudragit RL100 based ... See full document

... IR spectra indicated the absence of probable chemical interaction between the drug and polymers used in three different proportions. Melting point of Bosentan was found to be 116.4 ° C.Characterization of granules ... See full document

... a sustained release ...for characterization including Transmission electron microscopy, X-ray diffraction, Encapsulation efficiency, Particle Size ...optimized formulation was 50 nm with ... See full document

... vitro release rate from sustained release tablet of Metformin hydrochloride based on a low density ...The sustained release drug delivery was a promising approach ... See full document

... Sustained release matrix tablets of metformin hydrochloride were prepared using different ratios of xanthan gum and HPMCK4 and HPMCK15 cellulose by direct compression ...the ... See full document

... formulations containing combinations of hydrophilic and hydrophobic polymers, FX, FXI, FXII, ...drug release as compared with 10 and 20% of either of the Eudragit ...burst release was observed, which ... See full document

... in matrix formulations containing propranolol hydrochloride ...fruit mucilage used as a matrix forming agent in design of sustained release matrix tablets of ... See full document

... Angle of repose: The angle of repose of tablet blends was determined by the funnel method. The blends were allowed to flow through the funnel freely onto the surface. The diameter of the powder cone was measured ... See full document

... bilayer tablet formulation containing Metformin hydrochloride as sustained release layer and Glimepiride as conventional immediate release ...Layer ... See full document

... of Sustained Release Tablet of Metformin Matrix tablets each containing 500 mg metformin hydrochloride was prepared by direct compression ... See full document

... drug release at 0.5hr), Q10 ( drug release at the 10hr), Q18 (drug release at 18hr), and f2 value were selected as dependent variables ...The formulation layout of the factorial batches ... See full document

... MetforminHCl controlled release tablets were prepared with guar gum and other additives. MetforminHCl and, lactose were mixed together, and granulate it with guar gum solution until a wet mass was obtained. Then ... See full document

... hydrochloride matrix tablets by using hydroxyl methyl cellulose polymer (HPMC) as rate controlling factor and to evaluate drug release parameters as per various release kinetic ...of ... See full document

... develop Sustained release matrix tablets of Dicyclomine hydrochloride to reduce the dosing frequency to twice daily thereby increasing patient compliance and therapeutic ...B9 ... See full document